Learn More
Medchemexpress LLC Indomethacin sodium hydrate | 74252-25-8 | MFCD00227184 | 99.85% | 10 MM * 1 ML in DMSO

Supplier: Medchemexpress LLC HY14397A10MM/1ML
Indomethacin sodium hydrate is an orally active and BBB-permeable COX1/2 inhibitor, demonstrating IC50 values of 18 nM for COX-1 and 26 nM for COX-2. It exhibits both anticancer and anti-infective activities, making it suitable for research in cancer, inflammation, and viral infections.
- In vitro studies show Indomethacin sodium hydrate (0-150 μM; 24 hours; 3LL-D122 cells) possesses anticancer activity.
- It protects host cells from virus-induced damage by activating PKR, which results in eIF2α phosphorylation.
- This mechanism leads to the inhibition of viral protein translation and replication, with an IC50 of 2 μM.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.